<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>News for Pain Therapeutics, Inc. - Google Finance</title>
<description>News for Pain Therapeutics, Inc. - Google Finance</description>
<link>http://www.google.com/finance?q=NASDAQ:PTIE&amp;amp;client=news-rss&amp;amp;ei=k8ubUcG7AfDq0QHTJw</link>
<image>
<title>News for Pain Therapeutics, Inc. - Google Finance</title>
<url>/finance/s/M4XFgDr56u4/images/logo_us.gif</url>
<link>http://www.google.com/finance?q=NASDAQ:PTIE&amp;amp;client=news-rss&amp;amp;ei=k8ubUcG7AfDq0QHTJw</link>
</image>
<item>
<title>Pfizer yet to decide on Pain Therapeutics&amp;#39; painkiller</title>
<link>http://www.reuters.com/article/2013/05/10/us-paintherapeutics-pfizer-painkiller-idUSBRE9490G720130510</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982057113954</guid>
<pubDate>Fri, 10 May 2013 12:01:10 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/article/2013/05/10/us-paintherapeutics-pfizer-painkiller-idUSBRE9490G720130510&quot; style=&quot;font-size:1.2em&quot;&gt;Pfizer yet to decide on Pain Therapeutics&amp;#39; painkiller&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 10, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;(Reuters) - Pfizer Inc said it could not decide whether to pursue regulatory approval for Pain Therapeutics Inc&amp;#39;s painkiller Remoxy, for which the United States Food and Drug Administration sought additional studies.&lt;/div&gt;
&lt;a href=&quot;http://globenewswire.com/news-release/2013/05/10/546185/10032338/en/Pain-Therapeutics-Files-Form-8-K-Regarding-Correspondence-From-Pfizer-Inc.html&quot;&gt;Pain Therapeutics Files Form 8-K Regarding Correspondence From Pfizer, Inc.&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;GlobeNewswire (press release)&lt;/span&gt;&lt;br&gt;
&lt;a href=&quot;http://www.schaeffersresearch.com/marketcenters/optionscenter/content/pain+therapeutics+inc+ptie+put+volume+skyrockets+as+stock+sinks/default.aspx?ID=116035&quot;&gt;Pain Therapeutics, Inc. (PTIE) Put Volume Skyrockets as Stock Sinks&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Schaeffers Research&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Pain Therapeutics Inc (NASDAQ:PTIE) up by 2.55%, Galantas Gold Corp (LON ...</title>
<link>http://gdpinsider.com/pain-therapeutics-inc-nasdaqptie-up-by-2-55-galantas-gold-corp-longal-1505.html</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://gdpinsider.com/pain-therapeutics-inc-nasdaqptie-up-by-2-55-galantas-gold-corp-longal-1505.html</guid>
<pubDate>Wed, 15 May 2013 12:07:07 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://gdpinsider.com/pain-therapeutics-inc-nasdaqptie-up-by-2-55-galantas-gold-corp-longal-1505.html&quot; style=&quot;font-size:1.2em&quot;&gt;Pain Therapeutics Inc (NASDAQ:PTIE) up by 2.55%, Galantas Gold Corp (LON ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;GSPInsider&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 15, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Miami, FL 05/15/2013 (GDPInsider) - Pain Therapeutics, Inc (NASDAQ:PTIE): Tuesday&amp;#39;s trading session saw Pain Therapeutics, Inc (NASDAQ:PTIE) shares headed 2.55% upward. The opening price of $2.78 touched an intraday high of $2.82 per share and ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Stocks to Watch: Gap, Pain Therapeutics, Air Lease</title>
<link>http://blogs.wsj.com/moneybeat/2013/05/10/stocks-to-watch-gap-pain-therapeutics-air-lease/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982056601772</guid>
<pubDate>Fri, 10 May 2013 13:17:03 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://blogs.wsj.com/moneybeat/2013/05/10/stocks-to-watch-gap-pain-therapeutics-air-lease/&quot; style=&quot;font-size:1.2em&quot;&gt;Stocks to Watch: Gap, Pain Therapeutics, Air Lease&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Wall Street Journal (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 10, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Among the companies with shares expected to actively trade in Friday&amp;#39;s session are Gap Inc. (GPS) Pain Therapeutics Inc. (PTIE) and Air Lease Corp (AL). Gap issued fiscal first-quarter projections that beat consensus estimates, while reporting same ...&lt;/div&gt;
&lt;a href=&quot;http://www.proactiveinvestors.com/companies/news/43729/fridays-most-followed-in-us-including-dell-nvidia-gap-pain-therapeutics-priceline-molycorp-hess-and-air-lease-43729.html&quot;&gt;Friday&amp;#39;s most followed in U.S. including Dell, Nvidia, Gap, Pain Therapeutics ...&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Proactive Investors USA &amp; Canada&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Primo Water Corporation (NASDAQ:PRMW) down by 3.92%, Pain Therapeutics ...</title>
<link>http://gdpinsider.com/primo-water-corporation-nasdaqprmw-down-by-3-92-pain-therapeutics-inc-nasdaqptie-1440.html</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982061503138</guid>
<pubDate>Tue, 14 May 2013 06:37:01 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://gdpinsider.com/primo-water-corporation-nasdaqprmw-down-by-3-92-pain-therapeutics-inc-nasdaqptie-1440.html&quot; style=&quot;font-size:1.2em&quot;&gt;Primo Water Corporation (NASDAQ:PRMW) down by 3.92%, Pain Therapeutics ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;GSPInsider&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 14, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Pain Therapeutics, Inc. (NASDAQ:PTIE) is raised by 2.61% in Monday trading and closed at $2.75, after starting its day with a value of $2.71.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Pain Therapeutics, Durect shares soar on Pfizer&amp;#39;s Remoxy comments</title>
<link>http://www.reuters.com/article/2013/04/30/us-paintherapeutics-durect-pfizer-idUSBRE93T0U920130430</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778139574264</guid>
<pubDate>Tue, 30 Apr 2013 17:23:06 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/article/2013/04/30/us-paintherapeutics-durect-pfizer-idUSBRE93T0U920130430&quot; style=&quot;font-size:1.2em&quot;&gt;Pain Therapeutics, Durect shares soar on Pfizer&amp;#39;s Remoxy comments&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 30, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;(Reuters) - Shares of Pain Therapeutics Inc (PTIE.O) and Durect Corp (DRRX.O) rose more than 40 percent after partner Pfizer Inc (PFE.&lt;/div&gt;
&lt;a href=&quot;http://www.bloomberg.com/news/2013-04-30/pain-therapeutics-durect-jump-as-pfizer-highlights-remoxy-drug.html&quot;&gt;Pain Therapeutics, Durect Jump as Pfizer Highlights Remoxy Drug&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Bloomberg&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Warner Chilcott Plc (NASDAQ:WCRX), Pain Therapeutics Inc. (NASDAQ:PTIE ...</title>
<link>http://www.sbwire.com/press-releases/warner-chilcott-plc-nasdaqwcrx-pain-therapeutics-inc-nasdaqptie-and-amarin-corporation-plc-nasdaqamrn-added-to-equity-profile-reports-nasdaq-gainers-watch-list-251268.htm</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.sbwire.com/press-releases/warner-chilcott-plc-nasdaqwcrx-pain-therapeutics-inc-nasdaqptie-and-amarin-corporation-plc-nasdaqamrn-added-to-equity-profile-reports-nasdaq-gainers-watch-list-251268.htm</guid>
<pubDate>Mon, 13 May 2013 19:29:25 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.sbwire.com/press-releases/warner-chilcott-plc-nasdaqwcrx-pain-therapeutics-inc-nasdaqptie-and-amarin-corporation-plc-nasdaqamrn-added-to-equity-profile-reports-nasdaq-gainers-watch-list-251268.htm&quot; style=&quot;font-size:1.2em&quot;&gt;Warner Chilcott Plc (NASDAQ:WCRX), Pain Therapeutics Inc. (NASDAQ:PTIE ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;SBWire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 13, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Pain Therapeutics Inc. (NASDAQ:PTIE) a biopharmaceutical company that develops novel drugs is currently up (+1.19%) on 893,973 shares traded after PAIN THERAPEUTICS INC Filed SEC form 8-K, Regulation FD Disclosure, Financial Statements and ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Investor Alert: Investigation of Pain Therapeutics, Inc. (NASDAQ:PTIE) Announced</title>
<link>http://www.sbwire.com/press-releases/investor-alert-investigation-of-pain-therapeutics-inc-nasdaqptie-announced-251337.htm</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982061321494</guid>
<pubDate>Tue, 14 May 2013 12:21:33 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.sbwire.com/press-releases/investor-alert-investigation-of-pain-therapeutics-inc-nasdaqptie-announced-251337.htm&quot; style=&quot;font-size:1.2em&quot;&gt;Investor Alert: Investigation of Pain Therapeutics, Inc. (NASDAQ:PTIE) Announced&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;SBWire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 14, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;San Diego, CA -- (SBWIRE) -- 05/14/2013 -- An investigation on behalf of investors of Pain Therapeutics, Inc. (NASDAQ:PTIE) shares over potential securities laws violations by Pain Therapeutics and certain of its directors and officers in connection ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>US HOT STOCKS: Molycorp, Pain Therapeutics, Restoration Hardware -2-</title>
<link>http://online.wsj.com/article/BT-CO-20130510-715051.html</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982057588950</guid>
<pubDate>Fri, 10 May 2013 22:19:39 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://online.wsj.com/article/BT-CO-20130510-715051.html&quot; style=&quot;font-size:1.2em&quot;&gt;US HOT STOCKS: Molycorp, Pain Therapeutics, Restoration Hardware -2-&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Wall Street Journal (India)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 10, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Drug developer Pain Therapeutics Inc. (PTIE, $2.68, -$2.64, -49.62%) said Pfizer Inc. (PFE, $28.72, +$0.12, +0.42%) is evaluating its participation in the development of the pain-medicine candidate Remoxy.&lt;/div&gt;
&lt;a href=&quot;http://online.wsj.com/article/BT-CO-20130510-710040.html?mod=googlenews_wsj&quot;&gt;US HOT STOCKS: Priceline.com, Pain Therapeutics, True Religion&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Wall Street Journal&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>NASDAQ Decliners Watch List: Pain Therapeutics Inc. (NASDAQ:PTIE ...</title>
<link>http://www.sbwire.com/press-releases/nasdaq-decliners-watch-list-pain-therapeutics-inc-nasdaqptie-durect-corporation-nasdaqdrrx-and-medivation-inc-nasdaqmdvn-added-to-equity-profile-reports-nasdaq-decliners-watch-list-250548.htm</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778149362925</guid>
<pubDate>Fri, 10 May 2013 19:03:37 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.sbwire.com/press-releases/nasdaq-decliners-watch-list-pain-therapeutics-inc-nasdaqptie-durect-corporation-nasdaqdrrx-and-medivation-inc-nasdaqmdvn-added-to-equity-profile-reports-nasdaq-decliners-watch-list-250548.htm&quot; style=&quot;font-size:1.2em&quot;&gt;NASDAQ Decliners Watch List: Pain Therapeutics Inc. (NASDAQ:PTIE ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;SBWire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 10, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Wilmington, DE -- (SBWIRE) -- 05/10/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Pain Therapeutics Inc. (NASDAQ:PTIE), DURECT Corporation (NASDAQ:DRRX), and Medivation, Inc. (NASDAQ:MDVN).&lt;/div&gt;
&lt;a href=&quot;http://www.4-traders.com/AFFYMAX-INC-39433/news/Affymax-Inc-AFFY-PTIE-and-DRRX-Added-to-Decliners-Watch-List-at-GSR-16840011/&quot;&gt;AFFYMAX, INC. : AFFY, PTIE and DRRX Added to Decliners Watch List at GSR&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;4-traders (press release)&lt;/span&gt;&lt;br&gt;
&lt;a href=&quot;http://gdpinsider.com/durect-corporation-nasdaqdrrx-down-by-42-13-affymax-inc-nasdaqaffy-1320.html&quot;&gt;DURECT Corporation (NASDAQ:DRRX) down by 42.13%, Affymax Inc ...&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;GSPInsider&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>NASDAQ Decliners Watch List: Affymax, Inc. (NASDAQ:AFFY) and Pain ...</title>
<link>http://www.sbwire.com/press-releases/nasdaq-decliners-watch-list-affymax-inc-nasdaqaffy-and-pain-therapeutics-inc-nasdaqptie-added-to-growing-stock-reports-nasdaq-decliners-watch-list-250397.htm</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982057332899</guid>
<pubDate>Fri, 10 May 2013 14:37:02 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.sbwire.com/press-releases/nasdaq-decliners-watch-list-affymax-inc-nasdaqaffy-and-pain-therapeutics-inc-nasdaqptie-added-to-growing-stock-reports-nasdaq-decliners-watch-list-250397.htm&quot; style=&quot;font-size:1.2em&quot;&gt;NASDAQ Decliners Watch List: Affymax, Inc. (NASDAQ:AFFY) and Pain ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;SBWire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 10, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Pain Therapeutics Inc. (NASDAQ:PTIE) a biopharmaceutical company that develops novel drugs is currently down (-48.87%) on 3,012,021 shares traded after Pain Therapeutics disclosed Pfizer reassessing continued Remoxy partnership.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
</channel>
</rss>
